CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
1.229
23.52%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.122
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 0.995
Open* 0.999
1-Year Change* 189.57%
Day's Range* 0.999 - 1.349
52 wk Range 0.25-2.11
Average Volume (10 days) 203.43K
Average Volume (3 months) 2.53M
Market Cap 50.45M
P/E Ratio -100.00K
Shares Outstanding 68.60M
Revenue 2.20M
EPS -0.75
Dividend (Yield %) N/A
Beta 0.00
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 18, 2024 1.229 0.231 23.15% 0.998 1.349 0.998
Mar 15, 2024 0.995 -0.244 -19.69% 1.239 1.299 0.969
Mar 14, 2024 1.249 0.060 5.05% 1.189 1.369 1.169
Mar 13, 2024 1.219 -0.050 -3.94% 1.269 1.369 1.219
Mar 12, 2024 1.329 0.120 9.93% 1.209 1.519 1.209
Mar 11, 2024 1.259 -0.040 -3.08% 1.299 1.309 1.229
Mar 8, 2024 1.199 -0.070 -5.52% 1.269 1.269 1.199
Mar 7, 2024 1.299 0.080 6.56% 1.219 1.379 1.199
Mar 6, 2024 1.259 0.050 4.14% 1.209 1.439 1.169
Mar 5, 2024 1.159 -0.050 -4.14% 1.209 1.309 1.159
Mar 4, 2024 1.199 -0.130 -9.78% 1.329 1.379 1.199
Mar 1, 2024 1.329 0.050 3.91% 1.279 1.379 1.219
Feb 29, 2024 1.289 0.000 0.00% 1.289 1.309 1.249
Feb 28, 2024 1.209 -0.040 -3.20% 1.249 1.299 1.179
Feb 27, 2024 1.309 -0.020 -1.50% 1.329 1.469 1.189
Feb 26, 2024 1.359 0.130 10.58% 1.229 1.449 1.109
Feb 23, 2024 1.269 0.210 19.83% 1.059 1.319 1.059
Feb 22, 2024 1.129 0.060 5.61% 1.069 1.179 1.069
Feb 21, 2024 1.129 -0.130 -10.33% 1.259 1.299 1.129
Feb 20, 2024 1.229 -0.140 -10.23% 1.369 1.369 1.229

Akso Health Group Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total revenue 13.1816 6 0 6.91447 3.69522
Revenue 13.1816 6 0 6.91447 3.69522
Total Operating Expense 27.4484 9.26046 4.24125 55.0202 10.8844
Selling/General/Admin. Expenses, Total 15.5358 3.06146 2.08663 22.2991 10.8844
Research & Development 1.03256 0
Operating Income -14.2669 -3.26046 -4.24125 -48.1057 -7.18919
Other, Net 1.20036 -0.74782 -0.05208 1.23216 0.38115
Net Income Before Taxes -13.0665 -4.00828 -4.29333 -46.8735 -6.80804
Net Income After Taxes -13.084 -4.1011 -4.29333 -47.3635 -7.61575
Net Income Before Extra. Items -13.1965 -4.10243 -4.29333 -47.3635 -7.61575
Net Income -1.35992 -16.8511 -34.827 -71.1984 5.53258
Income Available to Common Excl. Extra. Items -13.1965 -4.10243 -4.29333 -47.3635 -7.61575
Income Available to Common Incl. Extra. Items -1.35992 -16.8511 -34.827 -71.1984 5.53258
Dilution Adjustment
Diluted Net Income -1.35992 -16.8511 -34.827 -71.1984 5.53258
Diluted Weighted Average Shares 68.5981 59.6121 48.838 48.7572 48.6932
Diluted EPS Excluding Extraordinary Items -0.19237 -0.06882 -0.08791 -0.97142 -0.1564
Diluted Normalized EPS -0.19237 -0.06882 -0.08791 -0.58227 -0.1564
Minority Interest -0.1125 -0.00133
Interest Expense (Income) - Net Operating 0 0.80414 2.15462 2.49871 0
Unusual Expense (Income) 29.1898 0
Total Extraordinary Items 11.8366 -12.7486 -30.5337 -23.8349 13.1483
Cost of Revenue, Total 11.9126 5.39487 0
Gross Profit 1.26899 0.60513 0
Mar 2023 Sep 2022 Mar 2022 Sep 2021 Mar 2021
Total revenue 1.30914 11.8724 5.75408 0.24592 0
Revenue 1.30914 11.8724 5.75408 0.24592 0
Total Operating Expense 14.5258 12.9226 0.54471 8.71575 4.24125
Selling/General/Admin. Expenses, Total 13.3444 2.10033 0.22 2.84146 2.08663
Research & Development 0.09108 -0.24023 0.24023
Interest Expense (Income) - Net Operating 0 0 0.20414 0.6 2.15462
Other Operating Expenses, Total -5.03406 5.03406
Operating Income -13.2167 -1.05019 5.20937 -8.46983 -4.24125
Other, Net -0.68801 1.88837 -0.31943 -0.42838 -0.05208
Net Income Before Taxes -13.9047 0.83818 4.88993 -8.89821 -4.29333
Net Income After Taxes -13.9105 0.82644 4.81502 -8.91611 -4.29333
Net Income Before Extra. Items -14.0069 0.81034 4.81369 -8.91611 -4.29333
Net Income -2.17026 0.81034 -7.93495 -8.91611 -34.827
Income Available to Common Excl. Extra. Items -14.0069 0.81034 4.81369 -8.91611 -4.29333
Income Available to Common Incl. Extra. Items -2.17026 0.81034 -7.93495 -8.91611 -34.827
Diluted Net Income -2.17026 0.81034 -7.93495 -8.91611 -34.827
Diluted Weighted Average Shares 68.5981 68.5981 68.549 50.6754 48.838
Diluted EPS Excluding Extraordinary Items -0.20419 0.01181 0.07022 -0.17595 -0.08791
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS -0.20419 0.01181 0.07022 -0.17595 -0.08791
Unusual Expense (Income)
Total Extraordinary Items 11.8366 -12.7486 0 -30.5337
Cost of Revenue, Total 1.18137 10.7312 5.39487
Gross Profit 0.12777 1.14122 0.35921
Minority Interest -0.0964 -0.0161 -0.00133
Total Adjustments to Net Income 0 0
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total Current Assets 20.4603 62.8065 30.1225 52.0182 97.6806
Cash and Short Term Investments 7.92447 18.43 15.1287 6.6681 57.3721
Cash & Equivalents 7.92447 18.43 15.1287 6.6681 57.3721
Total Receivables, Net 9.2259 20 14.401 36.2627 36.9735
Prepaid Expenses 0.27213 0.17698 0.59278 0.40082 3.33497
Total Assets 20.4603 62.8065 31.6855 80.4762 173.256
Property/Plant/Equipment, Total - Net 0.06689 0.76357 1.25372
Note Receivable - Long Term 1.49612 22.3081 39.8105
Other Long Term Assets, Total 3.78633 3.72118
Total Current Liabilities 11.6208 50.5209 14.414 12.3618 26.5627
Accrued Expenses 0.93877 0.22588 1.14251 1.89035 2.7911
Notes Payable/Short Term Debt 9.68615 37.2 2.96878 2.09368 0
Other Current Liabilities, Total 0.99586 13.095 0.30268 8.37774 23.7716
Total Liabilities 11.735 50.5229 14.414 32.3753 46.7527
Total Long Term Debt 0 0 0 20 20
Total Equity 8.7253 12.2836 17.2715 48.1009 126.503
Common Stock 0.00698 0.00698 0.005 0.005 0.00496
Additional Paid-In Capital 71.0219 71.0219 60.6151 60.5596 59.8069
Retained Earnings (Accumulated Deficit) -54.4676 -53.1077 -36.2566 -1.42962 69.7688
Other Equity, Total -3.8476 -1.64922 -3.10354 -7.0457 -1.75696
Total Liabilities & Shareholders’ Equity 20.4603 62.8065 31.6855 80.4762 173.256
Total Common Shares Outstanding 49.2041
Accounts Receivable - Trade, Net 7.69698 0 0.02836 0.00188 0.41864
Property/Plant/Equipment, Total - Gross 0.13197 0.80927 1.99927
Accumulated Depreciation, Total -0.06508 -0.0457 -0.74555
Long Term Investments 0 1.6 30.7898
Long Term Debt 0 20 20
Other Liabilities, Total 0 0.0135 0.18996
Treasury Stock - Common -3.98837 -3.98837 -3.98837 -3.98837 -1.32047
Other Current Assets, Total 1.35135 16.4037 0 8.68651
Current Port. of LT Debt/Capital Leases 10 0
Total Inventory 1.68645 7.79582
Minority Interest 0.11421 0.00198
Mar 2023 Sep 2022 Mar 2022 Sep 2021 Mar 2021
Total Current Assets 20.4603 20.871 62.8065 22.3104 30.1225
Cash and Short Term Investments 7.92447 9.99056 18.43 15.4568 15.1287
Cash & Equivalents 7.92447 9.99056 18.43 15.4568 15.1287
Total Receivables, Net 9.2259 7.92858 20 6.56152 14.3892
Accounts Receivable - Trade, Net 7.69698 7.92858 0 0.01776 0.02836
Prepaid Expenses 0.27213 2.05229 0.17698 0.29201 0.60452
Total Assets 20.4603 20.9073 62.8065 32.5244 31.6855
Property/Plant/Equipment, Total - Net 0.03631 0.06881 0.06689
Long Term Investments 0
Note Receivable - Long Term 0 1.49612
Other Long Term Assets, Total 10.1453
Total Current Liabilities 11.6208 10.9772 50.5209 12.9722 14.414
Accrued Expenses 0.93877 1.18238 0.22588 0.945 1.14251
Notes Payable/Short Term Debt 9.68615 9.68615 37.2 2 2.96878
Other Current Liabilities, Total 0.99586 0.10871 13.095 0.02725 0.30268
Total Liabilities 11.735 10.9944 50.5229 12.9722 14.414
Total Long Term Debt 0 0 0 0 0
Long Term Debt 0
Other Liabilities, Total 0
Total Equity 8.7253 9.91285 12.2836 19.5522 17.2715
Common Stock 0.00698 0.00698 0.00698 0.00698 0.005
Additional Paid-In Capital 71.0219 71.0219 71.0219 71.0219 60.6151
Retained Earnings (Accumulated Deficit) -54.4676 -52.2973 -53.1077 -45.1727 -36.2566
Treasury Stock - Common -3.98837 -3.98837 -3.98837 -3.98837 -3.98837
Other Equity, Total -3.8476 -4.83032 -1.64922 -2.31557 -3.10354
Total Liabilities & Shareholders’ Equity 20.4603 20.9073 62.8065 32.5244 31.6855
Total Common Shares Outstanding
Other Current Assets, Total 1.35135 16.4037 0
Current Port. of LT Debt/Capital Leases 10 10
Total Inventory 1.68645 0.89956 7.79582
Minority Interest 0.11421 0.01721 0.00198
Property/Plant/Equipment, Total - Gross 0.12593
Accumulated Depreciation, Total -0.08962
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -16.8497 -31.5522 -47.3635 5.53258 65.5106
Cash From Operating Activities -8.62837 10.0585 -58.2787 -1.73108 87.723
Cash From Operating Activities 0.01839 0.01516 0.12052 0.4068 0.17438
Deferred Taxes 0 0 3.3083 -3.72408 0.41562
Changes in Working Capital -2.56415 23.2255 -32.9 -11.6206 19.7935
Cash From Investing Activities -19.9639 -0.00066 12.7754 -68.1066 -27.6238
Capital Expenditures -0.00486 0 -0.20036 -0.94481 -0.45603
Cash From Financing Activities 34.7811 -9.03722 -1.55219 -0.02938 47.5163
Financing Cash Flow Items 10.0172 0.03694 7.36367 -0.318 4.24256
Issuance (Retirement) of Stock, Net 0 0.00001 -2.26261 -0.16385 43.2737
Foreign Exchange Effects 0.60772 3.18293 0.60864 -5.38333 5.77472
Net Change in Cash 6.7966 4.20351 -46.4469 -75.2503 113.39
Non-Cash Items 10.7671 18.3701 18.556 7.67422 1.82887
Cash Taxes Paid 0.03862 0.00976 3.20938 12.2482 1.01696
Other Investing Cash Flow Items, Total -19.959 -0.00066 12.9757 -67.1617 -27.1678
Total Cash Dividends Paid 0 0 -19.5475
Issuance (Retirement) of Debt, Net 24.7639 -9.07416 -6.65324 20
Sep 2022 Mar 2022 Sep 2021 Mar 2021 Sep 2020
Net income/Starting Line 0.82644
Cash From Operating Activities -1.33412
Cash From Operating Activities 0.01384
Non-Cash Items 0
Changes in Working Capital -2.17439
Cash From Investing Activities 20
Other Investing Cash Flow Items, Total 20
Cash From Financing Activities -27.5138
Financing Cash Flow Items -27.5138
Foreign Exchange Effects -3.0868
Net Change in Cash -11.9348
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Renaissance Technologies LLC Hedge Fund 0.8998 214398 -19300 2023-06-30 HIGH
Two Sigma Investments, LP Hedge Fund 0.4789 114093 -6920 2023-06-30 HIGH
Rhumbline Advisers Ltd. Partnership Investment Advisor 0.0837 19940 19940 2023-06-30 LOW
HRT Financial LP Investment Advisor 0.0423 10073 10073 2023-06-30 HIGH
Morgan Stanley & Co. LLC Research Firm 0.0141 3370 0 2023-06-30 MED

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Akso Health Group Company profile

About Akso Health Group - ADR

Akso Health Group, formerly Xiaobai Maimai Inc, is a China-based company mainly engaged in e-commerce business. The Company provides services through the Xiaobai Maimai application (APP), a one-stop e-commerce platform. The Company provides products covering food and beverage, wine, cosmetic products, fashion and apparel, entertainment, houseware, home appliances and others.

Financial summary

BRIEF: For the six months ended 30 September 2021, AksoHealth Group - ADR revenues decreased 82% to $246K. Netloss before extraordinary items decreased 49% to $8.9M.Revenues reflect Interest income decrease of 82% to $187K,Commission services decrease of 81% to $60K. Lower net lossreflects Provision for uncollectable loans receiv decreaseof 61% to $5M (expense), General and administrativedecrease of 25% to $2.3M (expense).

Industry: E-commerce & Auction Services

Rm 8201-4-4(A) 2Nd Floor Qiantongyua Bld
No. 44 Moscow Rd Qianwan Bonded Port Are
BEIJING
BEIJING 0000
CN

Income Statement

  • Annual
  • Quarterly

News

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

Four reasons why Bitcoin is surging to record highs

Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.

10:18, 14 March 2024

China’s National People’s Congress: The markets have again been left wanting more

China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.

08:23, 8 March 2024
Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

13:14, 6 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

People also watch

US100

17,932.70 Price
-0.250% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 1.8

XRP/USD

0.60 Price
-3.020% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Gold

2,153.49 Price
-0.330% 1D Chg, %
Long position overnight fee -0.0188%
Short position overnight fee 0.0106%
Overnight fee time 22:00 (UTC)
Spread 0.50

BTC/USD

64,147.15 Price
-4.830% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading